These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17124504)

  • 21. Skin exposure to weak and moderate contact allergens induces IFNgamma production by lymph node cells of CD4+ T-cell-depleted mice.
    Vocanson M; Hennino A; Rozières A; Cluzel-Tailhardat M; Poyet G; Valeyrie M; Bénetière J; Tédone R; Kaiserlian D; Nicolas JF
    J Invest Dermatol; 2009 May; 129(5):1185-91. PubMed ID: 19005487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential.
    Schreiner M; Peiser M; Briechle D; Stahlmann R; Zuberbier T; Wanner R
    Allergy; 2007 Dec; 62(12):1419-28. PubMed ID: 17983376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved metal allergen reactivity of artificial skin models by integration of Toll-like receptor 4-positive cells.
    Frings VG; Müller D; Storz G; Rossi A; Sennefelder H; Adam C; Goebeler M; Groeber-Becker FK; Schmidt M
    Contact Dermatitis; 2019 Oct; 81(4):254-261. PubMed ID: 31198997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of multiple cytochrome p450 enzymes and multidrug resistance-associated transport proteins in human skin keratinocytes.
    Baron JM; Höller D; Schiffer R; Frankenberg S; Neis M; Merk HF; Jugert FK
    J Invest Dermatol; 2001 Apr; 116(4):541-8. PubMed ID: 11286621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response.
    Dhingra N; Shemer A; Correa da Rosa J; Rozenblit M; Fuentes-Duculan J; Gittler JK; Finney R; Czarnowicki T; Zheng X; Xu H; Estrada YD; Cardinale I; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol; 2014 Aug; 134(2):362-72. PubMed ID: 24768652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic.
    Eilstein J; Léreaux G; Budimir N; Hussler G; Wilkinson S; Duché D
    Arch Toxicol; 2014 Sep; 88(9):1681-1694. PubMed ID: 24658324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of pre- and pro-haptens with a β-galactosidase-expressing E. coli culture system for skin sensitization.
    Nepal MR; Kang MJ; Kim GH; Cha DH; Nam DH; Jeong TC
    Toxicol Lett; 2019 May; 305():81-93. PubMed ID: 30711672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis.
    Larsen JM; Bonefeld CM; Poulsen SS; Geisler C; Skov L
    J Allergy Clin Immunol; 2009 Feb; 123(2):486-92. PubMed ID: 18986691
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
    Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
    Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical responses of skin to allergenic and non-allergenic nitrohalobenzenes. Evidence that an NADPH-dependent reductase in skin may act as a prohapten-activating enzyme.
    Schmidt RJ; Chung LY
    Arch Dermatol Res; 1992; 284(7):400-8. PubMed ID: 1288421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin contact irritation conditions the development and severity of allergic contact dermatitis.
    Bonneville M; Chavagnac C; Vocanson M; Rozieres A; Benetiere J; Pernet I; Denis A; Nicolas JF; Hennino A
    J Invest Dermatol; 2007 Jun; 127(6):1430-5. PubMed ID: 17273160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD.
    Saint-Mezard P; Krasteva M; Chavagnac C; Bosset S; Akiba H; Kehren J; Kanitakis J; Kaiserlian D; Nicolas JF; Berard F
    J Invest Dermatol; 2003 Apr; 120(4):641-7. PubMed ID: 12648229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cytochrome P450 1 (CYP1) and N-acetyltransferase 1 (NAT1) activities in HaCaT cells: implications for the development of in vitro techniques for predictive testing of contact sensitizers.
    Bonifas J; Hennen J; Dierolf D; Kalmes M; Blömeke B
    Toxicol In Vitro; 2010 Apr; 24(3):973-80. PubMed ID: 20036732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro approaches to the identification and characterization of skin sensitizers.
    Basketter D; Maxwell G
    Cutan Ocul Toxicol; 2007; 26(4):359-73. PubMed ID: 18058309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug skin metabolites and allergic drug reactions.
    Merk HF
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):311-5. PubMed ID: 19535973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association between interleukin-6 production by contact allergen-activated draining lymph node cells and lymphoproliferative activity.
    Lappin MB; Dearman RJ; Norval M; Kimber I
    Am J Contact Dermat; 1998 Mar; 9(1):34-9. PubMed ID: 9471985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cytochrome P450 activity in vitro, using dermal and hepatic microsomes from four species and two keratinocyte cell lines in culture.
    Rolsted K; Kissmeyer AM; Rist GM; Hansen SH
    Arch Dermatol Res; 2008 Jan; 300(1):11-8. PubMed ID: 17992533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse.
    Dinger J; Meyer MR; Maurer HH
    Toxicol Lett; 2014 Oct; 230(1):28-35. PubMed ID: 25111188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.